Cargando…

A Novel Solid-Phase Site-Specific PEGylation Enhances the In Vitro and In Vivo Biostabilty of Recombinant Human Keratinocyte Growth Factor 1

Keratinocyte growth factor 1 (KGF-1) has proven useful in the treatment of pathologies associated with dermal adnexae, liver, lung, and the gastrointestinal tract diseases. However, poor stability and short plasma half-life of the protein have restricted its therapeutic applications. While it is pos...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Zhifeng, Zhu, Guanghui, Sun, Chuanchuan, Zhang, Jingui, Zhang, Yi, Zhang, Youting, Ye, Chaohui, Wang, Xiaojie, Ilghari, Dariush, Li, Xiaokun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3344868/ https://www.ncbi.nlm.nih.gov/pubmed/22574160 http://dx.doi.org/10.1371/journal.pone.0036423

Ejemplares similares

A Better Anti-Diabetic Recombinant Human Fibroblast Growth Factor 21 (rhFGF21) Modified with Polyethylene Glycol
por: Huang, Zhifeng, et al.
Publicado: (2011)

Quality Control of Widely Used Therapeutic Recombinant Proteins by a Novel Real-Time PCR Approach
por: Mamnoon, Babak, et al.
Publicado: (2016)

Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours
por: Infante, Jeffrey R, et al.
Publicado: (2018)

Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours
por: Infante, Jeffrey R, et al.
Publicado: (2018)

Characterization of inhibitory effects of the potential therapeutic inhibitors, benzoic acid and pyridine derivatives, on the monophenolase and diphenolase activities of tyrosinase
por: Gheibi, Nematollah, et al.
Publicado: (2015)

Pharmacokinetics of PEGylated Recombinant Human Erythropoietin in Rats
por: Cao, Xiaohan, et al.
Publicado: (2014)

Site-Specific PEGylation of Therapeutic Proteins
por: Dozier, Jonathan K., et al.
Publicado: (2015)

The Remarkable Roles of the Receptor for Advanced Glycation End Products (RAGE) and Its Soluble Isoforms in COVID-19: The Importance of RAGE Pathway in the Lung Injuries
por: Salehi, Mitra, et al.
Publicado: (2022)

Dissolution enhancement of efavirenz by solid dispersion and PEGylation techniques
por: Madhavi, B. Bindu, et al.
Publicado: (2011)

Novel site-specific PEGylated L-asparaginase
por: Meneguetti, Giovanna Pastore, et al.
Publicado: (2019)

GlycoPEGylated recombinant factor IX for hemophilia B in context
por: Santagostino, Elena, et al.
Publicado: (2018)

Protein PEGylation: Navigating Recombinant Protein Stability, Aggregation, and Bioactivity
por: Zuma, Lindiwe Khumbuzile, et al.
Publicado: (2022)

Mapping the prothrombin-binding site of pseutarin C by site-directed PEGylation
por: Üstok, Fatma Işık, et al.
Publicado: (2022)

CD8+ T cell stimulation with pegylated recombinant human IL-10 in the patient with advanced solid tumors - a Phase I study
por: Naing, Aung, et al.
Publicado: (2015)

Site-specific PEGylation of lidamycin and its antitumor activity
por: Li, Liang, et al.
Publicado: (2015)

Correction: Novel site-specific PEGylated L-asparaginase
por: Meneguetti, Giovanna Pastore, et al.
Publicado: (2019)

From Synthesis to Characterization of Site-Selective PEGylated Proteins
por: Belén, Lisandra Herrera, et al.
Publicado: (2019)

Site-Specific PEGylated Adeno-Associated Viruses with Increased Serum Stability and Reduced Immunogenicity
por: Yao, Tianzhuo, et al.
Publicado: (2017)

Chemosynthesis and characterization of site-specific N-terminally PEGylated Alpha-momorcharin as apotential agent
por: Sun, Wenkui, et al.
Publicado: (2018)

Expression and Purification of Human Keratinocyte Growth Factor 2 by Fusion with SUMO
por: Wu, Xiaoping, et al.
Publicado: (2008)

Pharmacokinetics of PEGylated Gold Nanoparticles: In Vitro—In Vivo Correlation
por: Dubaj, Tibor, et al.
Publicado: (2022)

Pharmacokinetics, Biodistribution, and Biosafety of PEGylated Gold Nanoparticles In Vivo
por: Kozics, Katarina, et al.
Publicado: (2021)

In vivo solid tumor targeting with recombinant VEGF-diphtheria immunotoxin
por: Hosseininejad-Chafi, Mohammad, et al.
Publicado: (2022)

Development of a novel DDS for site-specific PEGylated proteins
por: Yoshioka, Yasuo, et al.
Publicado: (2011)

Potential role of a new PEGylated recombinant factor VIII for hemophilia A
por: Wynn, Tung Thanh, et al.
Publicado: (2016)

Engineering of the Recombinant Expression and PEGylation Efficiency of the Therapeutic Enzyme Human Thymidine Phosphorylase
por: Karamitros, Christos S., et al.
Publicado: (2021)

74 In vivo Selection of S. aureus agr Mutants in Human Keratinocytes
por: Paulino, Franklin, et al.
Publicado: (2014)

Engineering a protease-based and site-specific PEGylation-based strategy for the controlled release of exenatide
por: Zhang, Aihong, et al.
Publicado: (2020)

In Vivo SELEX of an Inhibitory NSCLC-Specific RNA Aptamer from PEGylated RNA Library
por: Wang, Hanlu, et al.
Publicado: (2017)

The Way that PEGyl-DSPC Liposomal Doxorubicin Particles Penetrate into Solid Tumor Tissue
por: Pan, Xing Qing, et al.
Publicado: (2006)

The impact of PEGylation patterns on the in vivo biodistribution of mixed shell micelles
por: Gao, Hongjun, et al.
Publicado: (2013)

Effects of PEGylation on the physicochemical properties and in vivo distribution of organic nanotubes
por: Ding, Wuxiao, et al.
Publicado: (2014)

Enhanced Efficacy of PEGylated Liposomal Cisplatin: In Vitro and In Vivo Evaluation
por: Ghaferi, Mohsen, et al.
Publicado: (2020)

Stability and biological activity evaluations of PEGylated human basic fibroblast growth factor
por: Hadadian, Shahin, et al.
Publicado: (2015)

Formulation and PEGylation optimization of the therapeutic PEGylated phenylalanine ammonia lyase for the treatment of phenylketonuria
por: Bell, Sean M., et al.
Publicado: (2017)

Effects of pegylated recombinant human granulocyte colony-stimulating factor on lymphocytes and white blood cells of patients with malignant tumor
por: Zhao, Tong, et al.
Publicado: (2023)

Solution Structure of the Mycobacterium tuberculosis EsxG·EsxH Complex: FUNCTIONAL IMPLICATIONS AND COMPARISONS WITH OTHER M. TUBERCULOSIS Esx FAMILY COMPLEXES
por: Ilghari, Dariush, et al.
Publicado: (2011)

Melanocyte-keratinocyte interactions in vivo: the fate of melanosomes.
por: Wolff, K.
Publicado: (1973)

Erratum: Engineering of the Recombinant Expression and PEGylation Efficiency of the Therapeutic Enzyme Human Thymidine Phosphorylase
por: Frontiers Production Office,
Publicado: (2022)

PEGylated Recombinant Adenosine Deaminase Maintains Detoxification and Lymphocyte Counts in Patients with ADA-SCID
por: Dorsey, Morna J., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pgvs8lp56896ffh8g325kd5qhc